2 years ago
Bristol Myers Squibb (NYSE: BMY) today announced that the Phase 3 CheckMate -816 trial met a primary endpoint of pathologic complete response (pCR) in resectable non-small cell lung cancer (NSCLC). In the trial, significantly more patients treated with Opdivo (nivolumab) plus chemotherapy before surgery showed no evidence of cancer cells […]
2 years ago
Icon Health & Fitness, a Logan, Utah-based provider of connected fitness equipment and software, received a $200m growth investment. The round was led by L Catterton, joined by existing investor Pamplona Capital Management. The company intends to use the funds to further accelerate its growth strategy of delivering its expansive range of […]
Technavio has been monitoring the aquaculture market and it is poised to grow by $ 48.88 bn during 2020-2024, progressing at a CAGR of almost 5% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. […]
